Akebia leases 43,474 sq ft in Waltham for HQ; amends CEO/CFO severance

Akebia Therapeutics, Inc.

Leases 28,518 sq ft office + 14,956 sq ft lab at 180 Third Ave, Waltham, MA; HQ relocation planned for Sept 2026.
Annual office rent starts at $898,317, lab rent at $1,046,920; initial 84-month term with 5-year renewal option.
Security deposit of $810,515 in irrevocable letter of credit; landlord pays all work costs.
CEO John Butler severance: 12 months salary (non-CIC) or 24 months salary + 200% bonus (CIC); full equity vest on CIC.
CFO Erik Ostrowski severance: 12 months salary (non-CIC) or 12 months salary + 100% bonus (CIC); full vest of pre-2026 grants on CIC.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

Akebia Therapeutics, Inc. entered into Lease Agreement with BP THIRD AVENUE LLC valued at Annual rent for Office Premises initially $898,317, for Lab Premises initially $1,046,920, with rent (effective 2026-01-27).

Action: entry
Agreement: lease
Counterparty: BP THIRD AVENUE LLC
Value: Annual rent for Office Premises initially $898,317, for Lab Premises initially $1,046,920, with rent
Effective: 2026-01-27

Exact text from the filing

On January 27, 2026, Akebia Therapeutics, Inc. (the “Company”) entered into a lease agreement (the “Lease”) with BP THIRD AVENUE LLC, a Delaware limited liability company (the “Landlord”), pursuant to which the Company will lease an aggregate of approximately 43,474 square feet, consisting of 28,518 square feet of office space (the “Office Premises”) and 14,956 square feet of laboratory space (the “Lab Premises”) located at the building commonly known as 180 CityPoint and numbered 180 Third Avenue, Waltham, Massachusetts 02451

View on SEC.gov

284 material agreements filed in the last 30 days. Browse all material agreements →

Akebia Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001517022-26-000008

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.